Seeking Alpha

Complete Genomics (GNOM) tacks on another 2.2% gain premarket after surging yesterday on news...

Complete Genomics (GNOM) tacks on another 2.2% gain premarket after surging yesterday on news that the Mayo Clinic will outsource whole human genome sequencing to the company. Shares are now up 59% YTD, but still trade at only a third of their 52-week highs.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|